bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.05.18.492367

Brain morphometric changes in congenitally blind subjects: a 7 Tesla MRI study

Abstract

We used ultra-high field (7 Tesla) magnetic resonance imaging (MRI) at submillimeter resolution to assess structural brain changes in congenitally blind (CB) compared to matched normal sighted control (SC) subject groups. Region-of-interest analysis revealed grey matter (GM) volumetric reductions in the CB group in left cuneus and occipital pole, right posterior collateral sulcus and right occipito-temporal medial lingual sulcus. Non-visual areas with GM reductions in CB included the left central, postcentral and superior frontal gyri, and the right subcallosal gyrus. In contrast, there were no significant group differences in cortical thickness when using stringent statistical criteria. Regional differences in white matter (WM) showed an overall pattern similar as that of GM changes, characterized by volume reductions in occipital, parietal and temporal areas, but with additional reductions in precuneus and medial orbitofrontal cortex. Differences in cortical curvature were mostly situated in the occipital cortex and bore a close relationship with areas showing GM alterations; they may be indicative of increased cortico-cortical connectivity of the visually-deprived occipital cortex. The CB group had GM reductions in the basal ganglia, i.e., caudate nucleus, putamen, nucleus accumbens, globus pallidus, and thalamus. Within the cerebellum, GM and WM volumes were also reduced in the CB. Segmentation of the thalamus, hippocampus and amygdala into anatomic divisions revealed GM reductions in a number of thalamic nuclei, a few hippocampal regions, but not within amygdala. There were no findings of increased volume or cortical thickness in the CB group. Together, these data reveal a multitude of GM and WM reductions in CB, comprising not only the occipital cortex, but also temporal, parietal, and prefrontal cortices, as well as the basal ganglia and cerebellum. These findings in the CB may seem at odds with the large literature showing that the visually-deprived occipital cortex becomes a multimodal cortex responding to diverse non-visual sensory and cognitive inputs. The seeming mismatch between morphological atrophy and enhanced multimodality of occipital areas combined with superior performance by the CB in various non-visual tasks poses a challenge for our understanding of brain plasticity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kupers, R., Zhan, M., Pare, S., Dricot, L., Vaessen, M., de Gelder, B.. 2022-05-20. Brain morphometric changes in congenitally blind subjects: a 7 Tesla MRI study. https://doi.org/10.1101/2022.05.18.492367

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗